About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

RECRUITINGNCT05051098

A Non-interventional Registry for Patients with Hepatitis B Virus Infection

In order to tackle the unmet needs in chronic HBV infection, a consortium of clinical partners has gathered to establish a registry for patients with hepatitis B mono- and co-infections. The partners ...

Lead sponsor: Hannover Medical School•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Petra Dörge

CONTACT

+49511532 doerge.petra@mh-hannover.de

Sponsors

Lead Sponsor

Hannover Medical School

Collaborators

European Union
German Center for Infection Research
German Liver Foundation (DLS)

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Hepatitis B Virus Infection
•TherVacB sub-cohort:
•confirmed chronic hepatitis B virus infection: HBsAg positive for at least 1 year prior inclusion
•HBeAg status documented for at least 6 months

Exclusion Criteria

•TherVacB sub-cohort:
•age \>70 years
•co-infection with HIV, HCV (RNA positive),
•clinically relevant concomitant liver diseases (ALD, NASH, Haemochromatosis, Autoimmune hepatitis, AT1, Wilson's disease, primary biliary cirrhosis etc.)
•significant comorbidities (e.g. malignancies)
•immunosuppressive treatment (\> 40 mg Cortisol- equivalent)
•liver cirrhosis (judged clinically or based on ultrasound/transient elastography)
•History of hepatocellular carcinoma

Related studies

RECRUITINGPhase 1

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection

NCT07024641 · Hepatitis B Virus Infection

Treatment and Prognosis of Patients With Chronic HBV Infection

NCT05392387 · Hepatitis B Virus Infection

Active Not RecruitingPhase 2

A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB)

NCT06537414 · Chronic Hepatitis B Virus Infection, Hepatitis B

Active Not RecruitingPhase 2

Study to Investigate the Efficacy and Safety of Regimens Containing BRII-179, BRII-835, and PEG-IFNα Treating Chronic Hepatitis B Virus (HBV) Infection (ENRICH)

NCT06491563 · For Treatment of Chronic Hepatitis B Virus Infection

Not Yet RecruitingPhase 2

Clinical Study to Evaluate the Efficacy and Safety of HH-006 in Patients With Chronic Hepatitis B Virus Infection

NCT07519330 · Chronic Hepatitis B Virus Infection

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 13, 2025Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment3,000

Start dateMay 2021

Last updatedMar 13, 2025

Condition

Hepatitis B Virus Infection

Locations shown

Hannover Medical School

Hanover

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 13, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions